Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1835664 (
TOC
)
2,763
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The photocatalytic degradation of 2-chlorophenol (2-CP) irradiated with visible light over iodine doped TiO(2) (IT) modified with SnO(2) (
SIT
) nanoparticles has been investigated in this study. The structure and optical properties of the
SIT
catalysts have been well characterized by X-ray diffraction, the Brunauer-Emmett-Teller method, transmission electron microscopy, UV-visible absorption spectra and X-ray photoelectron spectroscopy. The effects of preparation conditions, such as SnO(2) content and calcination temperature, on the photocatalytic degradation efficiency have been surveyed in detail. The improved photocatalytic activity of
SIT
is derived from the synergistic effect between the SnO(2) and IT, which promoted the efficiency of migration of the photogenerated carriers at the interface of the catalysts and thereby enhanced the efficiency of photon harvesting in the visible region. The action of scavengers (fluoride ion, iodide ion, tert-butyl alcohol, and persulfate ion), as well as N(2) purging on the photodegradation rate reveal that the valence band hole is mainly responsible for the effective photocatalytic removal of 2-CP and the corresponding
TOC
reduction.
...
PMID:Increasing the catalytic activities of iodine doped titanium dioxide by modifying with tin dioxide for the photodegradation of 2-chlorophenol under visible light irradiation. 2142 66